Resolian

Resolian is a global Contract Research Organization (CRO) that specializes in bioanalysis, drug metabolism/pharmacokinetics (DMPK), and GMP CMC analytical and materials science. Founded in 2008 in Malvern, Pennsylvania, the company has grown through strategic mergers and now operates with over 500 experts across facilities in the US, UK, Australia, and China. Resolian is committed to supporting pharmaceutical and biotech companies throughout the drug development process, from preclinical stages to multi-regional clinical trials. The company offers a range of integrated services, including GxP and non-regulated bioanalysis, DMPK studies, and GMP CMC testing. Its laboratories utilize advanced technology and emphasize regulatory compliance, ensuring high-quality results. Resolian's mission is to accelerate drug development, and it aims to lead in providing analytical solutions globally. The leadership team includes CEO Rob Stachlewitz and other key executives who guide the company's strategic direction and operations.